MAM
GMAB icon

Marotta Asset Management’s Genmab GMAB Stock Holding History

Marotta Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Sell
11,427
-293
-3% -$7.79K 0.05% 81
2026
Q1 		$319K Sell
11,720
-150
-1% -$4.5K 0.06% 81
2025
Q4 		$366K Sell
11,870
-53
-0.4% -$1.65K 0.07% 76
2025
Q3 		$379K Sell
11,923
-161
-1% -$3.92K 0.07% 75
2025
Q2 		$250K Sell
12,084
-1,448
-11% -$29.7K 0.05% 86
2025
Q1 		$330K Buy
13,532
+739
+6% +$15.5K 0.06% 95
2024
Q4 		$269K Sell
12,793
-739
-5% -$16.2K 0.06% 98
2024
Q3 		$330K Sell
13,532
-111
-0.8% -$2.97K 0.06% 95
2024
Q2 		$339K Sell
13,643
-1,399
-9% -$39.7K 0.07% 90
2024
Q1 		$450K Sell
15,042
-523
-3% -$15.4K 0.09% 73
2023
Q4 		$496K Sell
15,565
-886
-5% -$27.8K 0.11% 67
2023
Q3 		$580K Sell
16,451
-563
-3% -$21.5K 0.13% 64
2023
Q2 		$647K Buy
+17,014
New +$678K 0.14% 60
2022
Q4 		$730K Sell
17,219
-49
-0.3% -$2.02K 0.18% 56
2022
Q3 		$555K Buy
17,268
+73
+0.4% +$2.56K 0.14% 58
2022
Q2 		$575K Sell
17,195
-62
-0.4% -$2.01K 0.14% 63
2022
Q1 		$624K Sell
17,257
-158
-0.9% -$5.42K 0.15% 65
2021
Q4 		$689K Buy
17,415
+359
+2% +$15K 0.16% 56
2021
Q3 		$745K Sell
17,056
-208
-1% -$9.34K 0.18% 52
2021
Q2 		$717K Buy
17,264
+1,924
+13% +$74.2K 0.17% 54
2021
Q1 		$505K Buy
+15,340
New +$577K 0.13% 59

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marotta Asset Management's GMAB Position: Q2 2026 in Review

Marotta Asset Management reduced its Genmab (GMAB) stake by 2.5% in Q2 2026, selling an estimated $7.79K and leaving 11,427 shares worth $316K. The position accounts for 0.05% of the portfolio, ranked #81.

Marotta Asset Management first reported a position in GMAB in Q1 2021 and has held it in 21 quarters since. The position peaked at $745K in Q3 2021. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Marotta Asset Management held 11,427 shares of Genmab worth $316K as of Q2 2026.
  • Marotta Asset Management sold 293 Genmab shares in Q2 2026, an estimated $7.79K.
  • Genmab made up 0.05% of Marotta Asset Management's portfolio in Q2 2026, its #81 holding.
  • Marotta Asset Management first reported a position in Genmab in Q1 2021 and has held it in 21 quarters since.
  • Marotta Asset Management's Genmab position peaked at $745K in Q3 2021.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Marotta Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.